2011

Fatal and non-fatal AIDS and non-AIDS events in HIV-1 positive individuals with high CD4 counts according to viral load strata.
Reekie J, Gatell J, Yust I, Bakowska E, Rakhmanova A, Losso M, Krasnov M, Francioli P, Kowalska J, Mocroft A, for the EuroSIDA in EuroCoord.
AIDS. 2011 Nov 28;25:2259-68. Abstract 

Rising HIV-1 viral load set point at a population level coincides with a fading impact of host genetic factors on HIV-1 control.
van Manen D, Gras L, Boeser-Nunnink BD, van Sighem AI, Maurer I, Mangas Ruiz MM, Harskamp AM, Steingrover R, Prins JM, de Wolf F, van 't Wout AB, Schuitemaker H; Dutch HIV monitoring foundation HIV-1 Host Genetics study.
AIDS. 2011 Nov 28;25(18):2217-26.  Abstract 

Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study.
Mugavero MJ, May M, Ribaudo HJ, Gulick RM, Riddler SA, Haubrich R, Napravnik S, Abgrall S, Phillips A, Harris R, Gill MJ, de Wolf F, Hogg R, Günthard HF, Chêne G, D’arminio Monforte A, Guest JL, Smith C, Murillas J, Berenguer J, Wyen C, Domingo P, Kitahata MM, Sterne JA, Saag MS; on behalf of the AIDS Clinical Trial Group DACS 241 team AIDS Clinical Trial Group Study 5095 team AIDS Clinical Trial Group Study 5142 team and the Antiretroviral Cohort Collaboration.
J Acquir Immune Defic Syndr. 2011 Nov 1;58(3):253-60,  Epub ahead of print Aug 18. Abstract

The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy.

Boer K, Smit C, van der Flier M, de Wolf F; ATHENA cohort study group.Eur J Public Health. 2011 Oct;21(5):632-7. Epub 2010 Nov 4.  Abstract

Time From Human Immunodeficiency Virus Seroconversion to Reaching CD4+ Cell Count Thresholds <200, <350, and <500 Cells/mm3: Assessment of Need Following Changes in Treatment Guidelines.
Lodi S, Phillips A, Touloumi G, Geskus R, Meyer L, Thiébaut R, Pantazis N, Amo JD, Johnson AM, Babiker A, Porter K; on behalf of the CASCADE Collaboration in EuroCoord.
Clin Infect Dis. 2011 Oct;53(8):817-825. Abstract

An international collaboration to standardize HIV-2 viral load assays: Results from the 2009 ACHIEV2E quality control study.

Damond F, Benard A, Balotta C, Böni J, Cotten M, Duque V, Ferns B, Garson J, Gomes P, Gonçalves F, Gottlieb G, Kupfer B, Ruelle J, Rodes B, Soriano V, Wainberg M, Taieb A, Matheron S, Chene G, Brun-Vezinet F; for the ACHIEV2E Study group.
J Clin Microbiol. 2011 Oct;49(10):3491-7. Epub 2011 Aug 3. Abstract

Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe.
Bailey H, Townsend C, Cortina-Borja M, Thorne C, European Collaborative Study in EuroCoord.
Antivir Ther. 2011;16(6):895-903. Abstract

The development of an expert system to predict virological response to HIV therapy as part of an on-line treatment support tool.
Revell AD, Wang D, Boyd MA, Emery S, Pozniak AL, De Wolf F, Harrigan PR, Montaner JS, Lane HC, Larder BA; on behalf of the RDI Study Group
AIDS. 2011 Sep 24;25(15):1855-1863. Epub 2011 Jul 21 Abstract

Developing quality indicators for the care of HIV-infected pregnant women in the Dutch Caribbean.
Hermanides HS, van Vught LA, Voigt R, Muskiet FD, Durand A, van Osch G, Koolman-Wever S, Gerstenbluth I, Smit C, Duits AJ. 
AIDS Res Ther. 2011 Sep 22;8(1):32. doi: 10.1186/1742-6405-8-32. Abstract

A376S in the Connection Subdomain of HIV-1 Reverse Transcriptase Confers Increased Risk of Virological Failure to Nevirapine Therapy.
Paredes R, Puertas MC, Bannister W, Kisic M, Cozzi-Lepri A, Pou C, Bellido R, Betancor G, Bogner J, Gargalianos P, Bánhegyi D, Clotet B, Lundgren J, Menéndez-Arias L, Martinez-Picado J; The EuroSIDA Study Group.
J Infect Dis. 2011 Sep;204(5):741-752. Abstract

Predictors of having a resistance test following confirmed virological failure of combination antiretroviral therapy: data from EuroSIDA.
Fox ZV, Cozzi-Lepri A, D'Arminio Monforte A, Karlsson A, Phillips AN, Kronborg G, Kjaer J, Clotet B, Lundgren JD; EuroSIDA.
Antivir Ther. 2011;16(5):781-5. Abstract

Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study.
Petoumenos K, Worm S, Reiss P, de Wit S, d'Arminio Monforte A, Sabin C, Friis-Møller N, Weber R, Mercie P, Pradier C, El-Sadr W, Kirk O, Lundgren J, Law M; for the D:A:D Study Group.
HIV Med. 2011 Aug;12(7):412-421. Epub 2011 Jan 20 Abstract

Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors.
Kruk A, Bannister W, Podlekareva DN, Chentsova NP, Rakhmanova AG, Horban A, Domingo P, Mocroft A, Lundgren JD, Kirk O; EuroSIDA study group.
AIDS. 2011 Jul 31;25(12):1505-13. Abstract

Immune reconstitution and risk of Kaposi sarcoma and non-Hodgkin lymphoma in HIV-infected adults.
Jaffe HW, De Stavola BL, Carpenter LM, Porter K, Cox DR; CASCADE Collaboration.
AIDS. 2011 Jul 17;25(11):1395-403. Abstract

The Coding Causes of Death in HIV (CoDe) Project: Initial Results and Evaluation of Methodology.
Kowalska JD, Friis-Møller N, Kirk O, Bannister W, Mocroft A, Sabin C, Reiss P, Gill J, Lewden C, Phillips A, D'arminio Monforte A, Law M, Sterne J, De Wit S, Lundgren JD; for The CoDe Working Group and the D:A:D Study Group.
Epidemiology. 2011 Jul;22(4):516-523. Abstract

Antenatal screening for HIV, hepatitis B and syphilis in the Netherlands is effective.
Op de Coul EL, Hahne S, van Weert YW, Oomen P, Smit C, van der Ploeg KP, Notermans DW, Boer K, Van der Sande MA.
BMC Infect Dis. 2011 Jun 30;11(1):185. Ned Tijdschr Geneeskd. 2010;154:A2175.
(In Dutch) Abstract 

Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study.
Viard JP, Souberbielle JC, Kirk O, Reekie J, Knysz B, Losso M, Gatell J, Pedersen C, Bogner JR, Lundgren JD, Mocroft A; EuroSIDA Study Group.
AIDS. 2011 Jun 19;25(10):1305-15. Abstract

HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4+ T-cell lymphocytes.
Bohlius J, Schmidlin K, Boué F, Fätkenheuer G, May M, Caro-Murillo AM, Mocroft A, Bonnet F, Clifford G, Paparizos V, Miro JM, Obel N, Prins M, Chêne G, Egger M; Collaboration of Observational HIV Epidemiological Research Europe.
Blood. 2011 Jun 9;117(23):6100-8. Epub 2011 Mar 2. Abstract

The Efficacy of Combination Antiretroviral Therapy in HIV Type 1-Infected Patients Treated in Curaçao Compared with Antillean, Surinam, and Dutch HIV Type 1-Infected Patients Treated in The Netherlands.
Hermanides HS, Gras L, Winkel CN, Gerstenbluth I, van Sighem A, de Wolf F, Duits AJ.
AIDS Res Hum Retroviruses. 2011 Jun;27(6):605-12. Epub 2010 Dec 14. Abstract

Immunodeficiency as a Risk Factor for Non-AIDS-Defining Malignancies in HIV-1-Infected Patients Receiving Combination Antiretroviral Therapy.
Kesselring A, Gras L, Smit C, van Twillert G, Verbon A, de Wolf F, Reiss P, Wit F.
Clin Infect Dis. 2011 Jun;52(12):1458-65. Abstract

Quadruple antiretrovirale therapie heeft geen virologisch voordeel bij de behandeling van hiv-naïeve patiënten met een hoge plasma ‘virale load’.
Grijsen ML, Holman R, Gras LAJ, de Wolf F, Prins JM, namens de ATHENA nationale observationele cohort studie
Tijdschrift voor Infectieziekten vol 6 nr. 4 2011(In Dutch)

Self-Reported Symptoms Among HIV-Infected Patients on Highly Active
Antiretroviral Therapy in the ATHENA Cohort in The Netherlands
de Boer M, Prins J.M, Sprangers M.A.G., Smit C, Nieuwkerk P.T.
HIV Clin Trials 2011;12(3):161–170 Abstract

HIV in hiding: methods and data requirements for the estimation of the number of people living with undiagnosed HIV.
Lodwick R, Alioum A, Archibald C, Birrell P, Commenges D, Costagliola D, De Angelis D, Donoghoe M, Garnett G, Ghys P, Law M, Lundgren J, Ndawinz J, Presanis A, Sabin C, Salminen M, Sommen C, Stanecki K, Stover J, Supervie V, Sweeting M, van de Laar M, van Sighem A, Wand H, Wilson D, Yan P, Phillips A. Working Group on Estimation of HIV Prevalence in Europe.
AIDS. 2011 May 15;25(8):1017-23. Abstract

Risk of triple-class virological failure in children with HIV: a retrospective cohort study.
Pursuing Later Treatment Options II (PLATO II) project team for the Collaboration of Observational HIV Epidemiological Research Europe (COHERE), Castro H, Judd A, Gibb DM, Butler K, Lodwick RK, van Sighem A, Ramos JT, Warsawski J, Thorne C, Noguera-Julian A, Obel N, Costagliola D, Tookey PA, Colin C, Kjaer J, Grarup J, Chene G, Phillips A.
Lancet. 2011 May 7;377(9777):1580-7. Epub 2011 Apr 20. Abstract 

Immunovirological Response to Triple Nucleotide Reverse-Transcriptase Inhibitors and Ritonavir-Boosted Protease Inhibitors in Treatment-Naive HIV-2-Infected Patients: The ACHIEV2E Collaboration Study Group.
Benard A, van Sighem A, Taieb A, Valadas E, Ruelle J, Soriano V, Calmy A, Balotta C, Damond F, Brun-Vezinet F, Chene G, Matheron S
Clin Infect Dis. 2011 May;52(10):1257-1266. Abstract

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study.
Wittkop L, Günthard HF, de Wolf F, Dunn D, Cozzi-Lepri A, de Luca A, Kücherer C, Obel N, von Wyl V, Masquelier B, Stephan C, Torti C, Antinori A, García F, Judd A, Porter K, Thiébaut R, Castro H, van Sighem AI, Colin C, Kjaer J, Lundgren JD, Paredes R, Pozniak A, Clotet B, Phillips A, Pillay D, Chêne G; for the EuroCoord-CHAIN study group.
Lancet Infect Dis. 2011 May;11(5):363-371. Epub 2011 Feb 25. Abstract

A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study.
Reekie J, Reiss P, Ledergerber B, Sedlacek D, Parczewski M, Gatell J, Katlama C, Fätkenheuer G, Lundgren JD, Mocroft A; EuroSIDA study group.
HIV Med. 2011 May;12(5):259-68.  Epub 2010 Aug 31. Abstract

When to Initiate Combined Antiretroviral Therapy to Reduce Mortality and AIDS-Defining Illness in HIV-Infected Persons in Developed Countries: An Observational Study.
HIV-CAUSAL Collaboration, Cain LE, Logan R, Robins JM, Sterne JA, Sabin C, Bansi L, Justice A, Goulet J, van Sighem A, de Wolf F, Bucher HC, von Wyl V, Esteve A, Casabona J, del Amo J, Moreno S, Seng R, Meyer L, Perez-Hoyos S, Muga R, Lodi S, Lanoy E, Costagliola D, Hernan MA.
Ann Intern Med. 2011 Apr 19;154(8):509-515. Abstract

A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study.
Kowalska JD, Mocroft A, Ledergerber B, Florence E, Ristola M, Begovac J, Sambatakou H, Pedersen C, Lundgren JD, Kirk O; Eurosida Study Group.
HIV Clin Trials. 2011 Mar-Apr;12(2):109-17. Abstract

Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy.
Bannister WP, Cozzi-Lepri A, Kjær J, Clotet B, Lazzarin A, Viard JP, Kronborg G, Duiculescu D, Beniowski M, Machala L, Phillips A; EuroSIDA group.
J Antimicrob Chemother. 2011 Apr;66(4):901-11. Epub 2011 Jan 31. Abstract 

Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test.
Gras L, van Sighem A, Bezemer D, Smit C, Wit F, de Wolf F; ATHENA national observational cohort study.
AIDS. 2011 Mar 27;25(6):813-8. Abstract

Global trends in molecular epidemiology of HIV-1 during 2000-2007.
Hemelaar J, Gouws E, Ghys PD, Osmanov S; WHO-UNAIDS Network for HIV Isolation and Characterisation.
AIDS. 2011 Mar 13;25(5):679-89.

HIV Transmission Patterns among The Netherlands, Suriname, and The Netherlands Antilles: A Molecular Epidemiological Study.
Kramer MA, Cornelissen M, Paraskevis D, Prins M, Coutinho RA, van Sighem AI, Sabajo L, Duits AJ, Winkel CN, Prins JM, van der Ende ME, Kauffmann RH, Op de Coul EL.
AIDS Res Hum Retroviruses. 2011 Feb;27(2):123-30. Epub 2010 Oct 7. Abstract

Adherence to HIV Therapeutic Drug Monitoring Guidelines in The Netherlands.
van Luin M, Wit FW, Smit C, Rigter IM, Franssen EJ, Richter C, Kroon F, de Wolf F, Burger DM.
Ther Drug Monit. 2011 Feb;33(1):32-39. Abstract

National estimate of HIV prevalence in the Netherlands: comparison and applicability of different estimation tools.
Van Veen M, Presanis AM, Conti S, Xiridou M, Rinder Stengaard A, Donoghoe MC, van Sighem A, van der Sande MA, De Angelis D.
AIDS. 2011 Jan 14;25(2):229-37. Abstract
 
 

Stichting HIV Monitoring

Stichting HIV Monitoring (SHM) levert een belangrijke en noodzakelijke bijdrage aan de zorg voor mensen met hiv in Nederland. Door middel van het verzamelen en bewerken van gecodeerde data van hiv-positieve personen uit het hele land draagt ons monitor-onderzoek structureel bij aan de kennis over hiv en stelt het behandelend artsen in staat om de zorg voor hun patiënten continu te verbeteren. Ons jaarlijkse Monitoring Report geeft waardevolle input voor het ontwikkelen van hiv-zorg en preventiebeleid in Nederland en binnen de Europese Unie.

Bezoekadres

Nicolaes Tulphuis
Tafelbergweg 51
1105 BD Amsterdam

Postadres

Academisch Medisch Centrum
Universiteit van Amsterdam
Meibergdreef 9 1105 AZ Amsterdam

© Stichting HIV Monitoring  | Disclaimer  | Colofon